---
title: "FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285115733.md"
description: "FibroBiologics, Inc. (Nasdaq: FBLG), a biotech firm holding over 270 patents, disclosed promising preclinical findings. The results indicate that utilizing human dermal fibroblast (HDF) spheroids topically can alter the burn wound environment positively. This treatment approach demonstrated the ability to decrease damaging inflammation, modify immune cell response, and lessen indicators of scar formation within eight days post-injury."
datetime: "2026-05-04T20:03:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285115733.md)
  - [en](https://longbridge.com/en/news/285115733.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285115733.md)
---

# FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring

FibroBiologics, Inc. (Nasdaq: FBLG), a biotech firm holding over 270 patents, disclosed promising preclinical findings. The results indicate that utilizing human dermal fibroblast (HDF) spheroids topically can alter the burn wound environment positively. This treatment approach demonstrated the ability to decrease damaging inflammation, modify immune cell response, and lessen indicators of scar formation within eight days post-injury.

### Related Stocks

- [FBLG.US](https://longbridge.com/en/quote/FBLG.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [FibroBiologics Reports Positive Preclinical Results For HDF Spheroids In Treating Burn Wounds](https://longbridge.com/en/news/285170233.md)
- [Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition](https://longbridge.com/en/news/286608288.md)
- [MiNK Therapeutics' Q1 net loss narrows slightly](https://longbridge.com/en/news/286558132.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)